Report cover image

Global Edema Clinical Trials Market Size study, by Phase (Phase I, Phase II, Phase III, Phase IV), by Participant (Pediatrics, Adults, Geriatrics), by Study Design (Interventional Trials, Observational Trials, Expanded Access Trials), by Type (Systemic Ed

Publisher Factview Research
Published Jul 03, 2025
Length 285 Pages
SKU # FAVR20379048

Description

The Global Edema Clinical Trials Market is valued at approximately USD 912.39 million in 2024 and is anticipated to grow with a healthy growth rate of 5.9% over the forecast period 2024-2034. Edema clinical trials are pivotal in advancing our understanding and treatment of fluid retention conditions, which are often manifestations of underlying health issues such as heart failure, kidney disease, and diabetes. These trials are crucial in evaluating new medications, therapies, or lifestyle interventions aimed at reducing swelling and enhancing patient outcomes. By leveraging advanced diagnostic tools and biomarkers, these trials not only improve treatment efficacy but also accelerate the development of targeted therapies for diverse patient populations.

The surge in the prevalence of edema-related conditions, driven by the global increase in cardiovascular diseases, kidney disorders, and diabetes, is a primary factor propelling the growth of the edema clinical trials market. As these conditions become more prevalent with an aging global population, the demand for innovative and effective treatments escalates, creating a robust pipeline for clinical research. Additionally, significant advancements in medical technology, particularly in imaging and monitoring techniques, have substantially improved the precision of clinical trials, thereby encouraging greater investment from pharmaceutical companies and research institutions. The market is further bolstered by substantial funding from both government bodies and private organizations, underscoring the critical importance of developing effective edema treatments. This financial support not only facilitates the research process but also enables quicker transitions from clinical trials to market-ready solutions, thereby enhancing the overall healthcare landscape.

In terms of regional analysis, North America held the largest revenue share in 2024, accounting for 41.4% of the market. This dominance is attributed to the region's sophisticated research infrastructure, extensive funding mechanisms, and the presence of numerous academic institutions and research facilities. These factors collectively enable the region to conduct high-quality clinical trials efficiently. Meanwhile, the Asia Pacific region is poised for rapid growth, with a projected CAGR of 6.1% over the forecast period. This growth is driven by the rising incidence of edema, coupled with the expansion of healthcare infrastructure and the burgeoning pharmaceutical industry in key markets such as China and India.

Major market players included in this report are:

Otsuka Holdings

F. Hoffmann-La Roche Ltd.

Novartis Pharmaceuticals

Bayer

Genentech, Inc

Biogen

Johnson & Johnson

Inflammasome Therapeutics

Sanofi S.A.

OcuTerra Therapeutics

The detailed segments and sub-segment of the market are explained below:

By Phase:
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
By Participant:
  • Pediatrics
  • Adults
  • Geriatrics
By Study Design:
  • Interventional Trials
  • Observational Trials
  • Expanded Access Trials
By Type:
  • Systemic Edema
  • Localized Edema
By Region:

North America
  • U.S.
  • Canada
Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
Latin America
  • Brazil
  • Mexico
  • RoLA
Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA
Years considered for the study are as follows:
  • Historical year – 2022
  • Base year – 2024
  • Forecast period – 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years from 2022 to 2034.
  • Annualized revenues and regional-level analysis for each market segment.
  • Detailed analysis of the geographical landscape with Country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of the competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

285 Pages
Chapter 1. Global Edema Clinical Trials Market Executive Summary
1.1. Global Edema Clinical Trials Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Phase
1.3.2. By Participant
1.3.3. By Study Design
1.3.4. By Type
1.4. Key Trends
1.5. Recession Impact
1.6 Investment Analysis
1.7 Investment Rationale
1.8 Key Industry Metrics
1.9. Analyst Recommendation & Conclusion
Chapter 2. Global Edema Clinical Trials Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Edema Clinical Trials Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Edema-Related Conditions
3.1.2. Advancements in Medical Technology
3.1.3. Government and Private Funding
3.2. Market Challenges
3.2.1. Regulatory Hurdles
3.3. Market Opportunities
3.3.1. Growing Demand for Personalized Medicine
3.3.2. Emerging Markets
Chapter 4. Global Edema Clinical Trials Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunities
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Edema Clinical Trials Market Size & Forecasts by Phase 2024-2034
5.1. Segment Dashboard
5.2. Global Edema Clinical Trials Market: Phase Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Phase I
5.2.2. Phase II
5.2.3. Phase III
5.2.4. Phase IV
Chapter 6. Global Edema Clinical Trials Market Size & Forecasts by Participant 2024-2034
6.1. Segment Dashboard
6.2. Global Edema Clinical Trials Market: Participant Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Pediatrics
6.2.2. Adults
6.2.3. Geriatrics
Chapter 7. Global Edema Clinical Trials Market Size & Forecasts by Study Design 2024-2034
7.1. Segment Dashboard
7.2. Global Edema Clinical Trials Market: Study Design Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Interventional Trials
7.2.2. Observational Trials
7.2.3. Expanded Access Trials
Chapter 8. Global Edema Clinical Trials Market Size & Forecasts by Type 2024-2034
8.1. Segment Dashboard
8.2. Global Edema Clinical Trials Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.2.1. Systemic Edema
8.2.2. Localized Edema
Chapter 9. Global Edema Clinical Trials Market Size & Forecasts by Region 2024-2034
9.1. North America Edema Clinical Trials Market
9.1.1. U.S. Edema Clinical Trials Market
9.1.1.1. Phase breakdown size & forecasts, 2024-2034
9.1.1.2. Participant breakdown size & forecasts, 2024-2034
9.1.1.3. Study Design breakdown size & forecasts, 2024-2034
9.1.2. Canada Edema Clinical Trials Market
9.1.2.1. Phase breakdown size & forecasts, 2024-2034
9.1.2.2. Participant breakdown size & forecasts, 2024-2034
9.1.2.3. Study Design breakdown size & forecasts, 2024-2034
9.2. Europe Edema Clinical Trials Market
9.2.1. U.K. Edema Clinical Trials Market
9.2.1.1. Phase breakdown size & forecasts, 2024-2034
9.2.1.2. Participant breakdown size & forecasts, 2024-2034
9.2.1.3. Study Design breakdown size & forecasts, 2024-2034
9.2.2. Germany Edema Clinical Trials Market
9.2.3. France Edema Clinical Trials Market
9.2.4. Spain Edema Clinical Trials Market
9.2.5. Italy Edema Clinical Trials Market
9.2.6. Rest of Europe Edema Clinical Trials Market
9.3. Asia-Pacific Edema Clinical Trials Market
9.3.1. China Edema Clinical Trials Market
9.3.1.1. Phase breakdown size & forecasts, 2024-2034
9.3.1.2. Participant breakdown size & forecasts, 2024-2034
9.3.1.3. Study Design breakdown size & forecasts, 2024-2034
9.3.2. India Edema Clinical Trials Market
9.3.3. Japan Edema Clinical Trials Market
9.3.4. Australia Edema Clinical Trials Market
9.3.5. South Korea Edema Clinical Trials Market
9.3.6. Rest of Asia Pacific Edema Clinical Trials Market
9.4. Latin America Edema Clinical Trials Market
9.4.1. Brazil Edema Clinical Trials Market
9.4.2. Mexico Edema Clinical Trials Market
9.4.3. Rest of Latin America Edema Clinical Trials Market
9.5. Middle East & Africa Edema Clinical Trials Market
9.5.1. Saudi Arabia Edema Clinical Trials Market
9.5.2. South Africa Edema Clinical Trials Market
9.5.3. Rest of Middle East & Africa Edema Clinical Trials Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Bayer
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Genentech, Inc
10.3.3. Biogen
10.3.4. Johnson & Johnson
10.3.5. Inflammasome Therapeutics
10.3.6. Sanofi S.A.
10.3.7. OcuTerra Therapeutics
10.3.8. Otsuka Holdings
10.3.9. F. Hoffmann-La Roche Ltd.
10.3.10. Novartis Pharmaceuticals
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us